Nuclear Medicine Communications, 0143-3636

Journal

  1. 2018
  2. 2016
  3. 2015
  4. 2014
  5. 2012
  6. de Haas, R. J., Wicherts, D. A., Hobbelink, M. G. G., van Diest, P. J., Vleggaar, F. P., Borel Rinkes, I. H. M., & van Hillegersberg, R. (2012). Sentinel lymph node mapping in colon cancer using radiocolloid as a single tracer: a feasibility study. Nuclear Medicine Communications, 33(8), 832-837. https://doi.org/10.1097/MNM.0b013e328353bc0c
  7. 2011
  8. Wolfensberger , SP., Maruyama, K., van Berckel, B. N. M., Lubberink, M., Airaksinen, AJ., Boellaard, R., ... Lammertsma, A. A. (2011). Quantification of the neurokinin 1 receptor ligand [¹¹C]R116301. Nuclear Medicine Communications, 32(10), 896-902. https://doi.org/10.1097/MNM.0b013e328347e96f
  9. 2010
  10. Wiering, B., Adang, E. M. M., van der Sijp, J. R. M., Roumen, R. M., de Jong, K. P., Comans, E. F. I., ... Oyen, W. J. G. (2010). Added value of positron emission tomography imaging in the surgical treatment of colorectal liver metastases. Nuclear Medicine Communications, 31(11), 938-944. https://doi.org/10.1097/MNM.0b013e32833fa9ba
  11. 2009
  12. 2008
  13. Cicone, F., Loose, D., Deron, P., Vermeersch, H., Signore, A., de Vyvere, F. V., ... de Wiele, C. V. (2008). Prognostic value of FDG uptake by the bone marrow in squamous cell carcinoma of the head and neck. Nuclear Medicine Communications, 29(5), 431-435.
  14. 2007
  15. 2006
  16. 2005
  17. De Man, S., Vlerick, P., Gemmel, P., De Bondt, P., Matthys, D., & Dierckx, RA. (2005). Impact of waiting on the perception of service quality in nuclear medicine. Nuclear Medicine Communications, 26(6), 541-547.
  18. 2004
  19. 2003
  20. 2002
  21. Ten Bokum, AMC., Rosmalen, JGM., Hofland, LJ., Krenning, EP., Van Hagen, PM., & Breeman, WAP. (2002). Tissue distribution of octreotide binding receptors in normal mice and strains prone to autoimmunity. Nuclear Medicine Communications, 23(10), 1009-1017.
  22. 2001
  23. Kuyvenhoven, JD., Ham, H., & Piepsz, A. (2001). Is deconvolution applicable to renography? Nuclear Medicine Communications, 22(11), 1255-1260.
  24. Versijpt, J., Decoo, D., Van Laere, KJR., Achten, E., Audenaert, K., D'Asseler, Y., ... Korf, J. (2001). Co-57 SPECT, Tc-99m-ECD SPECT, MRI and neuropsychological testing in senile dementia of the Alzheimer type. Nuclear Medicine Communications, 22(6), 713-719.
  25. 1998
  26. Stevens, H., Knollema, S., Piers, DA., Van de Wiele, C., Jansen, HML., De Jager, AEJ., ... Korf, J. (1998). Cobalt-57 as a SPET tracer in the visualization of ischaemic brain damage in patients with middle cerebral artery stroke. Nuclear Medicine Communications, 19(6), 573-580.
  27. 1997
  28. Muntinga, H. J., van der Berg, F., Knol, M., & van der Wall, E. E. (1997). Quantification of the atrial contribution to diastolic filling during rad. Nuclear Medicine Communications, 18, 642 - 647.
  29. 1995
  30. JOOSTEN, AAJ., JANSEN, HML., PIERS, DA., MINDERHOUD, JM., & KORF, J. (1995). CO-57 SPET IN RELAPSING-PROGRESSIVE MULTIPLE-SCLEROSIS - A PILOT-STUDY. Nuclear Medicine Communications, 16(8), 703-705.

ID: 845699